4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0000921895-21-002700
Options or other derivatives
- Director acquired 204,041 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gayko Urte · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-03 | Grant or award : show line 1 in the form Stock Option (right to buy) | +200,000 | 200,000 | D |
| 2021-11-03 | Grant or award : show line 2 in the form Stock Option (right to buy) | +4,041 | 204,041 | D |
Loading xslF345X03/form412566001_11162021.xml…